Browsing by Subject "vaccination"

Now showing items 1-2 of 2

Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients

Chanchlani, N.; Lin, S.; Chee, D.; Hamilton, B.; Nice, R.; Zehra, A.; Bewshea, C.; Cipriano, B.; Derikx, Laap; Dunlop, A.; Greathead, L.; Griffiths, R. L.; Ibraheim, H.; Kelleher, P.; Kok, K. B.; Lees, C. W.; MacDonald, J.; Sebastian, S.; Smith, P. J.; McDonald, T. J.; Irving, P. M.; Powell, N.; Kennedy, N. A.; Goodhand, J. R.; Ahmad, T. (Oxford University Press, 2021-09-02)

BACKGROUND AND AIMS: Infliximab attenuates serological responses to SARS-CoV-2 infection. Whether this is a class effect, or if anti-TNF level influences serological responses, remains unknown. METHODS: Seroprevalence and ...
Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example

Shiri, T.; Evans, M.; Talarico, C. A.; Morgan, A. R.; Mussad, M.; Buck, P. O.; McEwan, P.; Strain, W. D. (MDPI, 2021-10-15)

Debate persists around the risk-benefit balance of vaccinating adolescents and children against COVID-19. Central to this debate is quantifying the contribution of adolescents and children to the transmission of SARS-CoV-2, ...